Home › Free Stock Grades › BMY
Bristol-Myers Squibb Company (BMY) Stock Grade
BMY · Healthcare
A+
Market Cap
$130.4B
P/E Ratio
15.6
Revenue Growth (YoY)
-0.2%
Net Margin
14.6%
Return on Equity
38.2%
Dividend Yield
4.6%
About Bristol-Myers Squibb Company's fundamentals
Bristol-Myers Squibb is a large-cap pharmaceutical company with a market capitalization of $130.4 billion that generates a 14.6% net profit margin on its operations. The company trades at a P/E ratio of 15.6 while delivering a robust 38.2% return on equity, though revenue contracted slightly by 0.2% year-over-year. With a 4.6% dividend yield, BMY provides meaningful income to shareholders alongside its substantial profitability metrics.